首页> 美国卫生研究院文献>Springer Open Choice >Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study

【2h】

Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study

机译：索拉非尼在日本肝细胞癌患者日常医疗实践中的安全性和有效性：一项前瞻性售后全患者监测研究的中期分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundSorafenib was approved for treatment of unresectable hepatocellular carcinoma (HCC) in Japan in 2009. A prospective postmarketing all-patient surveillance (PMS) study was requested by Japanese authorities to confirm safety and effectiveness of sorafenib in Japanese HCC population.

机译：背景技术索拉非尼于2009年在日本被批准用于治疗不可切除的肝细胞癌（HCC）。日本当局要求进行前瞻性上市后全病人监护（PMS）研究，以确认索拉非尼在日本HCC人群中的安全性和有效性。

著录项

期刊名称 Springer Open Choice
作者
Shuichi Kaneko; Kenji Ikeda; Yasushi Matsuzaki; Junji Furuse; Hironobu Minami; Yutaka Okayama; Toshiyuki Sunaya; Yuichiro Ito; Lyo Inuyama; Kiwamu Okita;
展开▼
作者单位

展开▼
年(卷),期 -1(51),10
年度 -1
页码 1011–1021
总页数 11
原文格式 PDF
正文语种
中图分类外科学;
关键词
Hepatocellular carcinoma Sorafenib Postmarketing surveillance Molecular targeted therapy Japanese;

机译：肝细胞癌;索拉非尼;上市后监测;分子靶向治疗;日语;

相似文献

外文文献
中文文献

1. Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study [J] . Kaneko Shuichi, Ikeda Kenji, Matsuzaki Yasushi, Journal of gastroenterology . 2016,第10期

机译：索拉非尼在日本肝细胞癌患者日常医疗实践中的安全性和有效性：一项前瞻性售后全患者监测研究的中期分析
2. Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study [J] . Kaneko Shuichi, Ikeda Kenji, Matsuzaki Yasushi, Journal of gastroenterology . 2016,第10期

机译：日本医学实践中日本肝细胞癌患者索拉非尼的安全性和有效性：临时分析临时邮政局全患者监测研究
3. A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance [J] . Akaza Hideyuki, Oya Mototsugu, Iijima Masafumi, Japanese journal of clinical oncology. . 2015,第10期

机译：甲苯磺酸索拉非尼在不可切除或转移性肾细胞癌中的安全性和有效性的大规模前瞻性注册研究：上市后全患者监测连续3200例以上的结果
4. IMANI-1 TC3WP Single Drug HAART -Proof of Concept Study Pilot Study of the Safety and Efficacy of Kaletra (LPV/r) as Single Drug HAART in HIV+ ARV- Naive Patients - Interim Analysis of Subjects Completing Final 48 Week Data [C] . J.C. Gathe Jr., M. Washington, C. Mayberry International AIDS Conference . 2004

机译：Imani-1 TC3WP单药搭载概念研究试验试验研究Kaletra（LPV / R）作为艾滋病毒+ ARV天真患者单药HAART的安全性和有效性 - 临时分析受试者完成最终的48周数据
5. Capture and Analysis of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma---Analysis of a Pilot Study [D] . Dong, Cheng. 2014

机译：肝细胞癌患者循环肿瘤细胞的捕获和分析---一项初步研究分析
6. A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance [O] . Hideyuki Akaza, Mototsugu Oya, Masafumi Iijima, -1

机译：甲磺酸索拉非尼在不可切除或转移性肾细胞癌中的安全性和有效性的大规模前瞻性注册研究：上市后全患者监测连续3200例以上的结果
7. Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study [O] . Shuichi Kaneko, Kenji Ikeda, Yasushi Matsuzaki, 2016

机译：索拉非尼在日本肝细胞癌患者日常医疗实践中的安全性和有效性：一项前瞻性售后全患者监测研究的中期分析

Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study

摘要

著录项

相似文献

相关主题

期刊订阅